Showing results (61-70 of 92) with videos related to
Sort By:
Pageof 10
Brain Research|May 4, 2004
Differential action potentials and firing patterns in injured and uninjured small dorsal root ganglion neurons after nerve injuryXu-Feng Zhang, Chang Z Zhu, Rama Thimmapaya, et al.Pharmacology, Biochemistry, and Behavior|August 15, 2002
Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia modelGerard B Fox, Jia Bao Pan, Timothy A Esbenshade, et al.The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterizationGerard B Fox, Jia Bao Pan, Richard J Radek, et al.Bioorganic & Medicinal Chemistry Letters|June 5, 2003
The discovery of a new class of large-conductance Ca2+-activated K+ channel opener targeted for overactive bladder: synthesis and structure-activity relationships of 2-amino-4-azaindolesSean C Turner, William A Carroll, Tammie K White, et al.Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Design and synthesis of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladderArturo Perez-Medrano, Steven A Buckner, Michael J Coghlan, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 8, 2011
Acute inhibition of 11beta-hydroxysteroid dehydrogenase type-1 improves memory in rodent models of cognitionEric G Mohler, Kaitlin E Browman, Victoria A Roderwald, et al.Journal of Medicinal Chemistry|October 4, 2011
Structure-activity studies of diazabicyclo[3.3.0]octane-substituted pyrazines and pyridines as potent α4β2 nicotinic acetylcholine receptor ligandsMarc J C Scanio, Lei Shi, William H Bunnelle, et al.British Journal of Pharmacology|October 23, 2009
Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptorsClark A Briggs, Jens Halvard Grønlien, Peter Curzon, et al.Journal of Medicinal Chemistry|November 2, 2007
Structure-activity studies of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladderArturo Perez-Medrano, Michael E Brune, Steven A Buckner, et al.Journal of Cardiovascular Pharmacology|July 27, 2005
Pharmacological characterization of the novel dihydropyridine potassium channel opener, (9R)-9-(3-iodo-4-methylphenyl)-5,9-dihydro-3H-furo[3,4-b]pyrano[4,3-e]pyridine-1,8(4H,7H)-dione (A-325100), and the regulation of cardiovascular function in conscious and anesthetized beagle dogsRyan M Fryer, Pamela A Rakestraw, Lee C Preusser, et al.Pageof 10